With quarantine infection numbers and border failures likely to keep increasing, the case for stricter travel restrictions is clear.
Academic rigour, journalistic flair
Articles on COVID-19 variants
Displaying 121 - 133 of 133 articles
Neutralising antibodies aren’t the only game in town.
Without improvements to New Zealand’s ‘makeshift’ border quarantine system the risk of further community cases of COVID-19 variants remains high.
The right to return is real but not absolute, and must be balanced with the rights of those already in New Zealand.
Scientists have observed that 501Y.V2 has quickly become “dominant” among multiple variants that have been circulating in the South African population.
A variant with a higher transmission rate is much more dangerous than one with just a higher fatality rate.
Multiple COVID-19 variants are circulating around the world and becoming more common. These mutations can alter the ability of the virus to take hold and replicate within our cells.
A virus that is 30% more transmissible is more deadly than a virus that is 30% more deadly. Counter-intuitive but true.
Your chance to ask a panel of experts about the coronavirus variants at 12.30pm GMT on Wednesday January 27.
So-called ‘variants of concern’ have been cropping up since November.
Analysis of smartphone data shows why countries need to coordinate border closures to stop the spread of the new variant.
It’s the part of coronavirus that helps the virus get into your cells – and also the target of the leading vaccines.
Mutations in BRCA genes are linked to the early onset of breast and ovarian cancers. But the effect of most mutations is unclear. Now new research can distinguish harmless from dangerous mutations.
Job Board
-
Sydney Horizon Educators (Identified)
-
Senior Disability Services Advisor
-
Deputy Social Media Producer
-
Associate Professor, Occupational Therapy
-
GRAINS RESEARCH AND DEVELOPMENT CORPORATION CHAIRPERSON
Top contributors
-
Professor in Applied Mathematics, University of Canterbury
-
Professor of Microbial Evolution at The Milner Centre for Evolution, University of Bath
-
Professor, Biochemistry, Trinity College Dublin
-
Professor of Physics, University of Auckland, Waipapa Taumata Rau
-
Senior Lecturer, The University of Queensland
-
Director: KRISP - KwaZulu-Natal Research and Innovation Sequencing Platform, University of KwaZulu-Natal
-
Professor, Biology, York University, Canada
-
Senior Lecturer, University of Auckland, Waipapa Taumata Rau
-
Professor of Public Health, University of Otago
-
Professor of Public Health, University of Otago
-
Early Career Research Leader, Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Instructor of Human Immunology, Emory University
-
Research Leader in Virology and Infectious Disease, Griffith University
-
Professor of Epidemiology, Medicine, and Infectious Diseases and Microbiology, University of Pittsburgh
